ChasingTheMoon

CUE PHARAM - 70% GAINS

Long
NASDAQ:CUE   Cue Biopharma, Inc
- Inverse head and shoulders pattern playing out on the trendline support
- Tipranks analyst consensus $31 Target of 121% upside
- Recent insider purchases, always a good sign
- CUE-101 Phase one is looking very promising
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.